| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Education, Public Health Professional | 2 | 2014 | 6 | 0.860 |
Why?
|
| Atrial Fibrillation | 18 | 2015 | 737 | 0.830 |
Why?
|
| Cardiovascular Diseases | 31 | 2016 | 2101 | 0.830 |
Why?
|
| Metabolic Syndrome | 14 | 2017 | 365 | 0.720 |
Why?
|
| Coronary Disease | 13 | 2010 | 627 | 0.590 |
Why?
|
| Risk Factors | 66 | 2021 | 10967 | 0.500 |
Why?
|
| Professional Competence | 2 | 2014 | 98 | 0.490 |
Why?
|
| Blood Pressure | 18 | 2016 | 1342 | 0.490 |
Why?
|
| Arginine | 7 | 2014 | 337 | 0.480 |
Why?
|
| Teaching | 2 | 2014 | 197 | 0.470 |
Why?
|
| Hypertension | 18 | 2015 | 1347 | 0.450 |
Why?
|
| Multivariate Analysis | 17 | 2017 | 1375 | 0.440 |
Why?
|
| Longitudinal Studies | 23 | 2021 | 1486 | 0.430 |
Why?
|
| Biostatistics | 1 | 2014 | 10 | 0.430 |
Why?
|
| Massachusetts | 20 | 2017 | 116 | 0.430 |
Why?
|
| Learning | 2 | 2014 | 368 | 0.410 |
Why?
|
| Middle Aged | 86 | 2017 | 28415 | 0.410 |
Why?
|
| Periodicals as Topic | 1 | 2016 | 182 | 0.410 |
Why?
|
| Insulin Resistance | 11 | 2014 | 687 | 0.410 |
Why?
|
| Incidence | 33 | 2017 | 3320 | 0.370 |
Why?
|
| Adipokines | 3 | 2017 | 118 | 0.360 |
Why?
|
| Biomarkers | 20 | 2017 | 3386 | 0.360 |
Why?
|
| Models, Statistical | 4 | 2014 | 484 | 0.350 |
Why?
|
| Aged | 64 | 2017 | 20899 | 0.350 |
Why?
|
| Body Mass Index | 18 | 2017 | 1679 | 0.340 |
Why?
|
| Proportional Hazards Models | 22 | 2017 | 1391 | 0.340 |
Why?
|
| Alcohol Drinking | 4 | 2021 | 338 | 0.330 |
Why?
|
| Male | 100 | 2020 | 64534 | 0.330 |
Why?
|
| Female | 104 | 2022 | 70425 | 0.330 |
Why?
|
| Biomedical Research | 1 | 2016 | 558 | 0.320 |
Why?
|
| Cohort Studies | 31 | 2017 | 5049 | 0.320 |
Why?
|
| Obesity | 14 | 2018 | 2384 | 0.310 |
Why?
|
| Adiponectin | 6 | 2017 | 122 | 0.310 |
Why?
|
| Risk Assessment | 14 | 2015 | 3678 | 0.310 |
Why?
|
| Diabetes Mellitus, Type 2 | 11 | 2011 | 1444 | 0.310 |
Why?
|
| Stroke | 8 | 2017 | 1060 | 0.300 |
Why?
|
| Aging | 6 | 2014 | 1244 | 0.300 |
Why?
|
| Humans | 114 | 2022 | 130555 | 0.290 |
Why?
|
| Gonadal Steroid Hormones | 3 | 2014 | 82 | 0.290 |
Why?
|
| Adult | 57 | 2021 | 31157 | 0.280 |
Why?
|
| Heart Failure | 11 | 2016 | 2326 | 0.260 |
Why?
|
| Cross-Sectional Studies | 24 | 2022 | 3797 | 0.260 |
Why?
|
| Ventricular Remodeling | 5 | 2014 | 154 | 0.260 |
Why?
|
| Prospective Studies | 27 | 2021 | 6438 | 0.230 |
Why?
|
| Follow-Up Studies | 23 | 2017 | 5164 | 0.230 |
Why?
|
| Predictive Value of Tests | 7 | 2017 | 2294 | 0.220 |
Why?
|
| Cognition Disorders | 5 | 2007 | 552 | 0.210 |
Why?
|
| Primary Health Care | 2 | 2001 | 769 | 0.210 |
Why?
|
| Knowledge | 2 | 2014 | 48 | 0.210 |
Why?
|
| Ventricular Dysfunction, Left | 4 | 2015 | 365 | 0.210 |
Why?
|
| Tobacco Smoking | 2 | 2021 | 21 | 0.210 |
Why?
|
| Stillbirth | 2 | 2022 | 96 | 0.200 |
Why?
|
| Biometry | 1 | 2004 | 100 | 0.200 |
Why?
|
| Goals | 2 | 2014 | 126 | 0.200 |
Why?
|
| Homocysteine | 5 | 2011 | 116 | 0.190 |
Why?
|
| Leptin | 4 | 2017 | 216 | 0.190 |
Why?
|
| Gonadotropins | 2 | 2013 | 31 | 0.190 |
Why?
|
| Motivation | 2 | 2014 | 327 | 0.180 |
Why?
|
| Sex Factors | 13 | 2016 | 1340 | 0.180 |
Why?
|
| Resistin | 3 | 2011 | 30 | 0.180 |
Why?
|
| Smoking | 8 | 2017 | 927 | 0.180 |
Why?
|
| Carbonated Beverages | 2 | 2014 | 11 | 0.170 |
Why?
|
| Child Health | 1 | 2022 | 68 | 0.170 |
Why?
|
| Community Health Workers | 1 | 2022 | 84 | 0.170 |
Why?
|
| Magnesium | 2 | 2012 | 114 | 0.170 |
Why?
|
| Hospitals, Municipal | 1 | 2001 | 2 | 0.170 |
Why?
|
| Diabetic Angiopathies | 3 | 2007 | 66 | 0.170 |
Why?
|
| Electrocardiography | 6 | 2015 | 975 | 0.170 |
Why?
|
| Outpatient Clinics, Hospital | 1 | 2001 | 72 | 0.160 |
Why?
|
| Aged, 80 and over | 20 | 2015 | 6800 | 0.160 |
Why?
|
| Diabetes Mellitus | 8 | 2017 | 891 | 0.160 |
Why?
|
| Retinol-Binding Proteins, Plasma | 3 | 2017 | 16 | 0.160 |
Why?
|
| alpha-2-HS-Glycoprotein | 3 | 2017 | 8 | 0.160 |
Why?
|
| Epidermolysis Bullosa Simplex | 1 | 2020 | 6 | 0.160 |
Why?
|
| Desmoplakins | 1 | 2020 | 12 | 0.160 |
Why?
|
| Fatty Acid-Binding Proteins | 3 | 2017 | 37 | 0.160 |
Why?
|
| Violence | 1 | 2001 | 128 | 0.160 |
Why?
|
| Echocardiography | 5 | 2014 | 1131 | 0.150 |
Why?
|
| Ectodermal Dysplasia | 1 | 2020 | 48 | 0.150 |
Why?
|
| Models, Biological | 1 | 2004 | 1383 | 0.150 |
Why?
|
| Cholesterol, HDL | 7 | 2011 | 385 | 0.150 |
Why?
|
| Prenatal Exposure Delayed Effects | 1 | 2021 | 231 | 0.150 |
Why?
|
| Curriculum | 2 | 2014 | 792 | 0.140 |
Why?
|
| Vascular Endothelial Growth Factor A | 2 | 2011 | 331 | 0.140 |
Why?
|
| Thyroiditis | 1 | 2017 | 3 | 0.140 |
Why?
|
| Pregnancy Outcome | 2 | 2021 | 614 | 0.140 |
Why?
|
| Goiter | 1 | 2017 | 9 | 0.140 |
Why?
|
| Vascular Stiffness | 2 | 2016 | 81 | 0.140 |
Why?
|
| Factor IX | 1 | 2017 | 17 | 0.140 |
Why?
|
| Hemophilia B | 1 | 2017 | 12 | 0.140 |
Why?
|
| Linear Models | 7 | 2015 | 686 | 0.140 |
Why?
|
| Thyroid Nodule | 1 | 2017 | 21 | 0.130 |
Why?
|
| Insulin-Like Growth Factor I | 3 | 2012 | 321 | 0.130 |
Why?
|
| Tumor Necrosis Factor-alpha | 3 | 2009 | 637 | 0.130 |
Why?
|
| Hypertrophy, Left Ventricular | 4 | 2015 | 109 | 0.130 |
Why?
|
| Child of Impaired Parents | 1 | 2017 | 20 | 0.130 |
Why?
|
| Carcinoma, Papillary | 1 | 2017 | 91 | 0.130 |
Why?
|
| Behavior Therapy | 2 | 2018 | 271 | 0.130 |
Why?
|
| Genome-Wide Association Study | 3 | 2014 | 1828 | 0.130 |
Why?
|
| Heart Ventricles | 4 | 2009 | 759 | 0.120 |
Why?
|
| Patient Satisfaction | 1 | 2000 | 462 | 0.120 |
Why?
|
| Mortality | 3 | 2009 | 261 | 0.120 |
Why?
|
| Transgenes | 1 | 2017 | 322 | 0.120 |
Why?
|
| Atrial Flutter | 2 | 2015 | 45 | 0.120 |
Why?
|
| Physician-Patient Relations | 1 | 2000 | 439 | 0.120 |
Why?
|
| Fasting | 3 | 2014 | 304 | 0.120 |
Why?
|
| Postpartum Period | 1 | 2018 | 237 | 0.120 |
Why?
|
| Vulnerable Populations | 1 | 2018 | 148 | 0.120 |
Why?
|
| Adenoma | 1 | 2017 | 143 | 0.120 |
Why?
|
| Antihypertensive Agents | 3 | 2015 | 415 | 0.120 |
Why?
|
| Transaminases | 2 | 2014 | 37 | 0.120 |
Why?
|
| Interleukin-1 Receptor-Like 1 Protein | 1 | 2016 | 22 | 0.120 |
Why?
|
| Growth Differentiation Factor 15 | 1 | 2016 | 26 | 0.120 |
Why?
|
| C-Reactive Protein | 6 | 2014 | 448 | 0.120 |
Why?
|
| Endothelium, Vascular | 2 | 2011 | 467 | 0.120 |
Why?
|
| Data Interpretation, Statistical | 1 | 2016 | 226 | 0.110 |
Why?
|
| Vulvar Neoplasms | 1 | 2015 | 18 | 0.110 |
Why?
|
| Fibroblast Growth Factors | 1 | 2016 | 171 | 0.110 |
Why?
|
| Cardiomyopathies | 1 | 2020 | 520 | 0.110 |
Why?
|
| Thyroid Neoplasms | 1 | 2017 | 244 | 0.110 |
Why?
|
| Blood Flow Velocity | 3 | 2012 | 417 | 0.110 |
Why?
|
| Troponin I | 1 | 2016 | 122 | 0.110 |
Why?
|
| Chromatography, Liquid | 3 | 2011 | 232 | 0.110 |
Why?
|
| Age Factors | 8 | 2014 | 2830 | 0.110 |
Why?
|
| Atrial Remodeling | 1 | 2014 | 16 | 0.110 |
Why?
|
| Sex Distribution | 7 | 2012 | 319 | 0.100 |
Why?
|
| Logistic Models | 6 | 2017 | 1793 | 0.100 |
Why?
|
| Carbon Monoxide | 1 | 2014 | 26 | 0.100 |
Why?
|
| Genetic Vectors | 1 | 2017 | 897 | 0.100 |
Why?
|
| United States | 16 | 2017 | 11883 | 0.100 |
Why?
|
| Receptor, TIE-2 | 2 | 2012 | 13 | 0.100 |
Why?
|
| Angiopoietin-2 | 2 | 2012 | 12 | 0.100 |
Why?
|
| Myocardial Infarction | 4 | 2015 | 1001 | 0.100 |
Why?
|
| Age Distribution | 6 | 2014 | 423 | 0.100 |
Why?
|
| Chromosomal Proteins, Non-Histone | 1 | 2015 | 210 | 0.100 |
Why?
|
| Tandem Mass Spectrometry | 3 | 2011 | 287 | 0.100 |
Why?
|
| Heart Murmurs | 2 | 2013 | 12 | 0.100 |
Why?
|
| Caffeine | 2 | 2010 | 66 | 0.100 |
Why?
|
| Time Factors | 10 | 2015 | 6215 | 0.100 |
Why?
|
| Magnesium Deficiency | 1 | 2012 | 10 | 0.100 |
Why?
|
| Models, Cardiovascular | 1 | 2014 | 167 | 0.100 |
Why?
|
| Carotid Artery Diseases | 2 | 2015 | 130 | 0.100 |
Why?
|
| Carcinoma | 1 | 2015 | 283 | 0.090 |
Why?
|
| Genetic Therapy | 1 | 2017 | 715 | 0.090 |
Why?
|
| Triglycerides | 4 | 2009 | 602 | 0.090 |
Why?
|
| Heart Atria | 3 | 2010 | 338 | 0.090 |
Why?
|
| Blood Glucose | 3 | 2016 | 1109 | 0.090 |
Why?
|
| Sarcoma | 1 | 2015 | 218 | 0.090 |
Why?
|
| Nitric Oxide Synthase | 2 | 2011 | 170 | 0.090 |
Why?
|
| Homes for the Aged | 1 | 1992 | 21 | 0.090 |
Why?
|
| Schizophrenia | 2 | 2005 | 323 | 0.090 |
Why?
|
| Stress, Psychological | 3 | 2007 | 538 | 0.090 |
Why?
|
| HIV Infections | 2 | 2005 | 2036 | 0.090 |
Why?
|
| Vascular Endothelial Growth Factors | 1 | 2012 | 47 | 0.090 |
Why?
|
| Prognosis | 8 | 2015 | 4867 | 0.090 |
Why?
|
| Nursing Homes | 1 | 1992 | 88 | 0.090 |
Why?
|
| Cause of Death | 6 | 2013 | 502 | 0.090 |
Why?
|
| Menopause | 1 | 2012 | 85 | 0.090 |
Why?
|
| Neuropsychological Tests | 5 | 2007 | 953 | 0.090 |
Why?
|
| Prevalence | 7 | 2021 | 2688 | 0.090 |
Why?
|
| Natriuretic Peptide, Brain | 2 | 2014 | 325 | 0.090 |
Why?
|
| Overweight | 3 | 2013 | 376 | 0.090 |
Why?
|
| Leukocyte Count | 1 | 2011 | 247 | 0.080 |
Why?
|
| Pedigree | 4 | 2020 | 1674 | 0.080 |
Why?
|
| Insulin | 2 | 2014 | 1140 | 0.080 |
Why?
|
| Brachial Artery | 1 | 2011 | 35 | 0.080 |
Why?
|
| Kidney Function Tests | 1 | 2011 | 135 | 0.080 |
Why?
|
| Fatty Acids, Unsaturated | 1 | 2010 | 67 | 0.080 |
Why?
|
| Dietary Fiber | 1 | 2010 | 77 | 0.080 |
Why?
|
| Young Adult | 8 | 2018 | 10015 | 0.080 |
Why?
|
| Insulin-Like Growth Factor Binding Proteins | 1 | 2010 | 33 | 0.080 |
Why?
|
| Regression Analysis | 5 | 2016 | 760 | 0.080 |
Why?
|
| Models, Theoretical | 1 | 1992 | 360 | 0.080 |
Why?
|
| Educational Status | 3 | 2006 | 277 | 0.080 |
Why?
|
| Vasodilation | 1 | 2011 | 175 | 0.080 |
Why?
|
| Receptors, Tumor Necrosis Factor, Type II | 1 | 2009 | 14 | 0.080 |
Why?
|
| Quality Control | 1 | 2010 | 115 | 0.080 |
Why?
|
| Tunica Media | 1 | 2009 | 15 | 0.080 |
Why?
|
| Adult Children | 1 | 2009 | 5 | 0.080 |
Why?
|
| Biomarkers, Tumor | 1 | 2017 | 1586 | 0.070 |
Why?
|
| South Africa | 2 | 2021 | 99 | 0.070 |
Why?
|
| Dietary Fats | 1 | 2010 | 275 | 0.070 |
Why?
|
| Tunica Intima | 1 | 2009 | 61 | 0.070 |
Why?
|
| Hepatocyte Growth Factor | 1 | 2009 | 33 | 0.070 |
Why?
|
| Substance-Related Disorders | 2 | 2006 | 489 | 0.070 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-1 | 1 | 2009 | 44 | 0.070 |
Why?
|
| Longevity | 1 | 2010 | 175 | 0.070 |
Why?
|
| Pregnancy | 6 | 2022 | 7403 | 0.070 |
Why?
|
| Reference Standards | 1 | 2009 | 232 | 0.070 |
Why?
|
| Polymorphism, Single Nucleotide | 3 | 2014 | 2826 | 0.070 |
Why?
|
| Aortic Diseases | 1 | 2010 | 187 | 0.070 |
Why?
|
| Dietary Supplements | 1 | 2011 | 449 | 0.070 |
Why?
|
| Cholesterol | 3 | 2005 | 537 | 0.070 |
Why?
|
| Odds Ratio | 4 | 2017 | 1210 | 0.070 |
Why?
|
| Risk | 5 | 2011 | 724 | 0.070 |
Why?
|
| Hemodynamics | 1 | 2012 | 809 | 0.070 |
Why?
|
| Lipoproteins, HDL | 1 | 2008 | 97 | 0.070 |
Why?
|
| Kaplan-Meier Estimate | 3 | 2017 | 1071 | 0.070 |
Why?
|
| Marriage | 1 | 2007 | 27 | 0.070 |
Why?
|
| Marital Status | 1 | 2007 | 33 | 0.070 |
Why?
|
| Apolipoproteins | 1 | 2007 | 69 | 0.070 |
Why?
|
| Algorithms | 2 | 2013 | 1665 | 0.070 |
Why?
|
| Receptors, Leptin | 2 | 2017 | 40 | 0.070 |
Why?
|
| Genotype | 2 | 2014 | 2592 | 0.060 |
Why?
|
| Hyperhomocysteinemia | 2 | 2004 | 37 | 0.060 |
Why?
|
| Myocardial Contraction | 1 | 2008 | 243 | 0.060 |
Why?
|
| DNA-Binding Proteins | 1 | 2015 | 1946 | 0.060 |
Why?
|
| Phosphorus | 1 | 2007 | 60 | 0.060 |
Why?
|
| Down Syndrome | 1 | 2009 | 233 | 0.060 |
Why?
|
| Infant, Low Birth Weight | 1 | 2007 | 169 | 0.060 |
Why?
|
| Adipose Tissue | 1 | 2009 | 499 | 0.060 |
Why?
|
| Quality of Health Care | 1 | 2010 | 408 | 0.060 |
Why?
|
| Hypertension, Pregnancy-Induced | 1 | 2007 | 80 | 0.060 |
Why?
|
| Mutation | 1 | 2020 | 6093 | 0.060 |
Why?
|
| Substance Abuse, Intravenous | 1 | 2006 | 42 | 0.060 |
Why?
|
| Reference Values | 3 | 2011 | 675 | 0.060 |
Why?
|
| Heart Diseases | 1 | 2010 | 501 | 0.060 |
Why?
|
| Aorta, Thoracic | 1 | 2010 | 527 | 0.060 |
Why?
|
| Transcription Factors | 1 | 2015 | 2420 | 0.060 |
Why?
|
| Diabetes Complications | 1 | 2007 | 197 | 0.060 |
Why?
|
| Lipoproteins, LDL | 1 | 2005 | 119 | 0.060 |
Why?
|
| Chromosome Disorders | 1 | 2007 | 316 | 0.060 |
Why?
|
| Cost of Illness | 1 | 2007 | 293 | 0.060 |
Why?
|
| Pre-Eclampsia | 1 | 2007 | 225 | 0.060 |
Why?
|
| Liver | 1 | 2012 | 1789 | 0.060 |
Why?
|
| Boston | 2 | 2005 | 117 | 0.050 |
Why?
|
| Kidney | 1 | 2011 | 1280 | 0.050 |
Why?
|
| Genetic Variation | 1 | 2011 | 1542 | 0.050 |
Why?
|
| Hyperuricemia | 1 | 2004 | 39 | 0.050 |
Why?
|
| Ultrasonography | 4 | 2011 | 946 | 0.050 |
Why?
|
| Hostility | 1 | 2004 | 20 | 0.050 |
Why?
|
| Uric Acid | 1 | 2004 | 110 | 0.050 |
Why?
|
| Ultrasonography, Prenatal | 1 | 2009 | 968 | 0.050 |
Why?
|
| Anger | 1 | 2004 | 31 | 0.050 |
Why?
|
| Adolescent | 8 | 2017 | 20774 | 0.050 |
Why?
|
| Cardiac Surgical Procedures | 1 | 2012 | 1158 | 0.050 |
Why?
|
| Occupational Diseases | 1 | 2004 | 77 | 0.050 |
Why?
|
| Congenital Abnormalities | 1 | 2007 | 325 | 0.050 |
Why?
|
| Kidney Failure, Chronic | 1 | 2011 | 937 | 0.050 |
Why?
|
| Confidence Intervals | 3 | 2012 | 270 | 0.050 |
Why?
|
| Genetic Predisposition to Disease | 2 | 2017 | 3407 | 0.050 |
Why?
|
| Premature Birth | 1 | 2007 | 420 | 0.050 |
Why?
|
| Infant Death | 1 | 2022 | 2 | 0.050 |
Why?
|
| Self Report | 2 | 2017 | 551 | 0.050 |
Why?
|
| Nepal | 1 | 2022 | 25 | 0.050 |
Why?
|
| Mental Health Services | 1 | 2006 | 284 | 0.050 |
Why?
|
| Alcoholism | 1 | 2005 | 244 | 0.050 |
Why?
|
| Calcium | 1 | 2007 | 1020 | 0.050 |
Why?
|
| Antipsychotic Agents | 1 | 2005 | 371 | 0.040 |
Why?
|
| Creatinine | 2 | 2016 | 396 | 0.040 |
Why?
|
| Adiposity | 2 | 2014 | 208 | 0.040 |
Why?
|
| South Dakota | 1 | 2021 | 1 | 0.040 |
Why?
|
| Patient Compliance | 1 | 2005 | 460 | 0.040 |
Why?
|
| North Dakota | 1 | 2021 | 5 | 0.040 |
Why?
|
| Albuminuria | 2 | 2015 | 105 | 0.040 |
Why?
|
| Socioeconomic Factors | 2 | 2004 | 903 | 0.040 |
Why?
|
| Anti-HIV Agents | 1 | 2005 | 347 | 0.040 |
Why?
|
| Chi-Square Distribution | 2 | 2017 | 564 | 0.040 |
Why?
|
| Insulin-Like Growth Factor Binding Protein 3 | 2 | 2012 | 43 | 0.040 |
Why?
|
| Glucose Intolerance | 3 | 2007 | 81 | 0.040 |
Why?
|
| Survival Rate | 3 | 2014 | 2114 | 0.040 |
Why?
|
| Rhode Island | 1 | 2000 | 6 | 0.040 |
Why?
|
| Mathematical Computing | 1 | 2000 | 9 | 0.040 |
Why?
|
| Medical History Taking | 1 | 2001 | 107 | 0.040 |
Why?
|
| Postoperative Complications | 1 | 2012 | 3115 | 0.040 |
Why?
|
| Hospitals, University | 1 | 2000 | 103 | 0.040 |
Why?
|
| Firearms | 1 | 2001 | 58 | 0.040 |
Why?
|
| Interview, Psychological | 1 | 2000 | 101 | 0.040 |
Why?
|
| Surveys and Questionnaires | 3 | 2010 | 4034 | 0.040 |
Why?
|
| Comorbidity | 4 | 2005 | 1583 | 0.040 |
Why?
|
| Quantitative Trait, Heritable | 2 | 2010 | 102 | 0.040 |
Why?
|
| Fatal Outcome | 1 | 2020 | 356 | 0.040 |
Why?
|
| Cholesterol, LDL | 3 | 2007 | 606 | 0.040 |
Why?
|
| Urban Population | 1 | 2001 | 282 | 0.040 |
Why?
|
| Organ Size | 2 | 2010 | 410 | 0.040 |
Why?
|
| Inflammation | 4 | 2010 | 1485 | 0.030 |
Why?
|
| Retrospective Studies | 5 | 2017 | 17557 | 0.030 |
Why?
|
| Population Surveillance | 3 | 2008 | 394 | 0.030 |
Why?
|
| Health Behavior | 1 | 2001 | 388 | 0.030 |
Why?
|
| Heredity | 1 | 2017 | 15 | 0.030 |
Why?
|
| Thyroid Gland | 1 | 2017 | 98 | 0.030 |
Why?
|
| Wounds and Injuries | 1 | 2001 | 393 | 0.030 |
Why?
|
| Cytokines | 1 | 2003 | 1343 | 0.030 |
Why?
|
| Indians, North American | 1 | 2017 | 71 | 0.030 |
Why?
|
| Sex Characteristics | 2 | 2012 | 322 | 0.030 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 1 | 2017 | 175 | 0.030 |
Why?
|
| Dependovirus | 1 | 2017 | 162 | 0.030 |
Why?
|
| Waist Circumference | 1 | 2016 | 92 | 0.030 |
Why?
|
| Proto-Oncogene Proteins B-raf | 1 | 2017 | 218 | 0.030 |
Why?
|
| DNA Mutational Analysis | 1 | 2017 | 778 | 0.030 |
Why?
|
| Ethanol | 1 | 2017 | 168 | 0.030 |
Why?
|
| Pulse Wave Analysis | 1 | 2015 | 52 | 0.030 |
Why?
|
| Asymptomatic Diseases | 1 | 2015 | 77 | 0.030 |
Why?
|
| Infant | 2 | 2022 | 13270 | 0.030 |
Why?
|
| Multiplex Polymerase Chain Reaction | 1 | 2015 | 35 | 0.030 |
Why?
|
| SMARCB1 Protein | 1 | 2015 | 41 | 0.030 |
Why?
|
| Registries | 1 | 2022 | 1614 | 0.030 |
Why?
|
| Non-Nutritive Sweeteners | 1 | 2014 | 1 | 0.030 |
Why?
|
| Nutritive Sweeteners | 1 | 2014 | 2 | 0.030 |
Why?
|
| Molecular Biology | 1 | 2015 | 66 | 0.030 |
Why?
|
| Amidohydrolases | 1 | 2014 | 21 | 0.030 |
Why?
|
| Sensitivity and Specificity | 2 | 2009 | 2085 | 0.030 |
Why?
|
| Propensity Score | 1 | 2015 | 272 | 0.030 |
Why?
|
| Radioimmunoassay | 1 | 2014 | 82 | 0.030 |
Why?
|
| Mediator Complex | 1 | 2014 | 62 | 0.030 |
Why?
|
| Substrate Specificity | 1 | 2014 | 285 | 0.030 |
Why?
|
| Hemorrhage | 1 | 2017 | 489 | 0.030 |
Why?
|
| Demography | 2 | 2005 | 237 | 0.030 |
Why?
|
| Fetus | 1 | 2017 | 567 | 0.030 |
Why?
|
| Breath Tests | 1 | 2014 | 182 | 0.020 |
Why?
|
| In Situ Hybridization, Fluorescence | 1 | 2015 | 742 | 0.020 |
Why?
|
| Heart Rate | 1 | 2016 | 574 | 0.020 |
Why?
|
| Cluster Analysis | 1 | 2014 | 412 | 0.020 |
Why?
|
| Gestational Age | 1 | 2017 | 1209 | 0.020 |
Why?
|
| Clinical Competence | 1 | 2000 | 1060 | 0.020 |
Why?
|
| Genetic Testing | 2 | 2010 | 1106 | 0.020 |
Why?
|
| Genetic Loci | 1 | 2014 | 353 | 0.020 |
Why?
|
| Protein Structure, Tertiary | 1 | 2014 | 716 | 0.020 |
Why?
|
| Interleukin-6 | 2 | 2006 | 412 | 0.020 |
Why?
|
| Alzheimer Disease | 1 | 2000 | 878 | 0.020 |
Why?
|
| Endothelium-Dependent Relaxing Factors | 1 | 2011 | 5 | 0.020 |
Why?
|
| HEK293 Cells | 1 | 2014 | 806 | 0.020 |
Why?
|
| England | 1 | 2011 | 57 | 0.020 |
Why?
|
| Binding Sites | 1 | 2014 | 1136 | 0.020 |
Why?
|
| Radioisotope Dilution Technique | 1 | 2011 | 37 | 0.020 |
Why?
|
| Potassium | 1 | 2012 | 265 | 0.020 |
Why?
|
| Immunohistochemistry | 1 | 2015 | 1599 | 0.020 |
Why?
|
| Disease Progression | 2 | 2010 | 2193 | 0.020 |
Why?
|
| Peripheral Arterial Disease | 1 | 2015 | 324 | 0.020 |
Why?
|
| Patient Admission | 1 | 1992 | 186 | 0.020 |
Why?
|
| Seafood | 1 | 2010 | 10 | 0.020 |
Why?
|
| Fishes | 1 | 2010 | 33 | 0.020 |
Why?
|
| Data Collection | 2 | 2005 | 370 | 0.020 |
Why?
|
| Colorimetry | 1 | 2010 | 16 | 0.020 |
Why?
|
| Community Health Services | 1 | 2011 | 86 | 0.020 |
Why?
|
| Diet Surveys | 1 | 2010 | 98 | 0.020 |
Why?
|
| Body Weight | 1 | 2014 | 986 | 0.020 |
Why?
|
| Systole | 1 | 2010 | 195 | 0.020 |
Why?
|
| Regional Blood Flow | 1 | 2011 | 192 | 0.020 |
Why?
|
| Pulsatile Flow | 1 | 2010 | 110 | 0.020 |
Why?
|
| Phenotype | 2 | 2011 | 4478 | 0.020 |
Why?
|
| Diagnosis, Differential | 1 | 2015 | 1877 | 0.020 |
Why?
|
| Europe | 1 | 2010 | 364 | 0.020 |
Why?
|
| Child | 2 | 2022 | 26175 | 0.020 |
Why?
|
| Treatment Outcome | 3 | 2015 | 12865 | 0.020 |
Why?
|
| Carotid Artery, Internal | 1 | 2009 | 55 | 0.020 |
Why?
|
| Carotid Artery, Common | 1 | 2009 | 59 | 0.020 |
Why?
|
| Observer Variation | 1 | 2010 | 311 | 0.020 |
Why?
|
| Gene Regulatory Networks | 1 | 2011 | 376 | 0.020 |
Why?
|
| Community Participation | 1 | 2009 | 42 | 0.020 |
Why?
|
| Genetic Linkage | 1 | 2010 | 461 | 0.020 |
Why?
|
| Glomerular Filtration Rate | 1 | 2011 | 568 | 0.020 |
Why?
|
| Sucrose | 1 | 2007 | 37 | 0.020 |
Why?
|
| Apolipoprotein A-I | 1 | 2007 | 80 | 0.020 |
Why?
|
| Likelihood Functions | 1 | 2007 | 115 | 0.020 |
Why?
|
| Sweetening Agents | 1 | 2007 | 37 | 0.020 |
Why?
|
| Residence Characteristics | 1 | 2010 | 293 | 0.020 |
Why?
|
| Apolipoproteins B | 1 | 2007 | 143 | 0.020 |
Why?
|
| Dyslipidemias | 1 | 2010 | 249 | 0.020 |
Why?
|
| Gene Frequency | 1 | 2008 | 731 | 0.020 |
Why?
|
| Pregnancy Trimester, First | 1 | 2007 | 115 | 0.020 |
Why?
|
| Stroke Volume | 1 | 2009 | 535 | 0.020 |
Why?
|
| Severity of Illness Index | 1 | 2014 | 3031 | 0.020 |
Why?
|
| Inactivation, Metabolic | 1 | 2006 | 25 | 0.010 |
Why?
|
| Hypertriglyceridemia | 1 | 2007 | 117 | 0.010 |
Why?
|
| Plasminogen Activator Inhibitor 1 | 1 | 2006 | 49 | 0.010 |
Why?
|
| Occupations | 1 | 2005 | 18 | 0.010 |
Why?
|
| P-Selectin | 1 | 2006 | 69 | 0.010 |
Why?
|
| Pyridoxine | 1 | 2005 | 15 | 0.010 |
Why?
|
| Intercellular Adhesion Molecule-1 | 1 | 2006 | 125 | 0.010 |
Why?
|
| Hemostasis | 1 | 2006 | 76 | 0.010 |
Why?
|
| Chemokine CCL2 | 1 | 2006 | 112 | 0.010 |
Why?
|
| Particle Size | 1 | 2005 | 136 | 0.010 |
Why?
|
| RNA, Messenger | 1 | 2011 | 2553 | 0.010 |
Why?
|
| Methadone | 1 | 2006 | 127 | 0.010 |
Why?
|
| Vitamin B 12 | 1 | 2005 | 59 | 0.010 |
Why?
|
| Narcotic Antagonists | 1 | 2006 | 110 | 0.010 |
Why?
|
| Probability | 1 | 2005 | 305 | 0.010 |
Why?
|
| Anthropometry | 1 | 2005 | 187 | 0.010 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2005 | 255 | 0.010 |
Why?
|
| Emotions | 1 | 2007 | 350 | 0.010 |
Why?
|
| Energy Intake | 1 | 2007 | 499 | 0.010 |
Why?
|
| Motor Activity | 1 | 2007 | 490 | 0.010 |
Why?
|
| von Willebrand Factor | 1 | 2006 | 191 | 0.010 |
Why?
|
| Type A Personality | 1 | 2004 | 3 | 0.010 |
Why?
|
| Life Style | 1 | 2007 | 444 | 0.010 |
Why?
|
| Cardiac Volume | 1 | 2004 | 17 | 0.010 |
Why?
|
| Social Class | 1 | 2006 | 212 | 0.010 |
Why?
|
| Lipids | 1 | 2007 | 560 | 0.010 |
Why?
|
| Language | 1 | 2005 | 215 | 0.010 |
Why?
|
| Job Satisfaction | 1 | 2004 | 99 | 0.010 |
Why?
|
| History, 21st Century | 1 | 2004 | 259 | 0.010 |
Why?
|
| Folic Acid | 1 | 2005 | 269 | 0.010 |
Why?
|
| Morbidity | 1 | 2004 | 257 | 0.010 |
Why?
|
| Personality Inventory | 1 | 2004 | 178 | 0.010 |
Why?
|
| Reproducibility of Results | 1 | 2010 | 2901 | 0.010 |
Why?
|
| History, 20th Century | 1 | 2004 | 363 | 0.010 |
Why?
|
| Angina Pectoris | 1 | 2002 | 56 | 0.010 |
Why?
|
| Recurrence | 1 | 2006 | 1478 | 0.010 |
Why?
|
| Feeding Behavior | 1 | 2007 | 708 | 0.010 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2003 | 353 | 0.010 |
Why?
|
| Parents | 1 | 2009 | 1118 | 0.010 |
Why?
|
| Adaptation, Psychological | 1 | 2004 | 430 | 0.010 |
Why?
|
| Clinical Trials as Topic | 1 | 2005 | 1127 | 0.010 |
Why?
|
| Diet | 1 | 2007 | 1099 | 0.010 |
Why?
|
| Hypercholesterolemia | 1 | 2002 | 231 | 0.010 |
Why?
|
| Anxiety | 1 | 2005 | 1007 | 0.010 |
Why?
|
| Cells, Cultured | 1 | 2003 | 2896 | 0.010 |
Why?
|
| Signal Transduction | 1 | 2010 | 4669 | 0.010 |
Why?
|
| Software | 1 | 2000 | 732 | 0.010 |
Why?
|
| Infant, Newborn | 1 | 2007 | 8546 | 0.010 |
Why?
|
| Animals | 1 | 2010 | 33856 | 0.000 |
Why?
|
| Neoplasms | 1 | 2004 | 2985 | 0.000 |
Why?
|